Frédéric Sottilini, CEO of Carthera
Yposkesi inaugurates €60M biomanufacturing site for cell and gene therapies
© Focus Kpture
Anoat Therapeutics raises €2M in seed funding to develop novel therapies for Cystic Fibrosis patients with high unmet medical need
Lynred breaks ground on new €85M industrial site for infrared technologies
©Hélène Bottarel/Groupe-6
DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes towards clinical development
Benjamin Charles, CEO at DiogenX – © DiogenX
Ciliatech raises €3.5M in Series A funding
© Studio CAP PHOTO